Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLCO2B1 | O94956 | 4/20 | 1.00 |
| ▸ | PTPN1 | P18031 | 3/20 | 1.00 |
| ▸ | SYNJ2 | O15056 | 1/20 | 0.86 |
| ▸ | KDM1A | O60341 | 2/20 | 0.79 |
| ▸ | CYP19A1 | P11511 | 4/20 | 0.79 |
| ▸ | GSK3B | P49841 | 3/20 | 0.79 |
| ▸ | UBE2N | P61088 | 1/20 | 0.79 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.70 |
| ▸ | P4HB | P07237 | 1/20 | 0.70 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.70 |
| ▸ | PKM | P14618 | 1/20 | 0.69 |
| ▸ | XDH | P47989 | 1/20 | 0.68 |
| ▸ | DPP4 | P27487 | 2/20 | 0.65 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.62 |
| ▸ | CALM1 | P0DP23 | 2/20 | 0.62 |
| ▸ | MEN1 | O00255 | 2/20 | 0.62 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.62 |
| ▸ | POLB | P06746 | 1/20 | 0.62 |
| ▸ | CACNA1B | Q00975 | 1/20 | 0.62 |
| ▸ | APBA1 | Q02410 | 1/20 | 0.62 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Prunin SCHEMBL13904742 | 1.00 | SLCO2B1 (1.00) | SLCO2B1PTPN1SYNJ2KDM1ACYP19A1 | |
| Prunin SCHEMBL29560212 | 1.00 | SLCO2B1 (1.00) | SLCO2B1PTPN1SYNJ2KDM1ACYP19A1 | |
| Prunin SCHEMBL31233345 | 1.00 | SLCO2B1 (1.00) | SLCO2B1PTPN1SYNJ2KDM1ACYP19A1 | |
| Prunin SCHEMBL29336352 | 1.00 | SLCO2B1 (1.00) | SLCO2B1PTPN1SYNJ2KDM1ACYP19A1 | |
| Prunin SCHEMBL2532187 | 1.00 | SLCO2B1 (1.00) | SLCO2B1PTPN1SYNJ2KDM1ACYP19A1 | |
| Prunin SCHEMBL1122487 | 1.00 | SLCO2B1 (1.00) | SLCO2B1PTPN1SYNJ2KDM1ACYP19A1 | |
| Prunin SCHEMBL13625098 | 1.00 | SLCO2B1 (1.00) | SLCO2B1PTPN1SYNJ2KDM1ACYP19A1 | |
| Prunin SCHEMBL31233342 | 1.00 | SLCO2B1 (1.00) | SLCO2B1PTPN1SYNJ2KDM1ACYP19A1 | |
| Prunin SCHEMBL318229 | 1.00 | SLCO2B1 (1.00) | SLCO2B1PTPN1SYNJ2KDM1ACYP19A1 | |
| SCHEMBL29822818 | 0.93 | PTPN1 (0.88) | SLCO2B1PTPN1SYNJ2KDM1ACYP19A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 497 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4108323-B1 | STABILIZER FOR EMULSION COMPOSITION | NAGASE VIITA CO LTD (JP) | 2025-10-15 | — | — | EP | claimed |
| US-12311001-B2 | Use of extracellular vesicles of Rhizoma Drynariae in preparation of medicine for treating orthopedic diseases | The Third Affiliated Hospital of Guangzhou University of Chinese Medicine (CN) | 2025-05-27 | — | — | US | claimed |
| US-20250000923-A1 | USE OF EXTRACELLULAR VESICLES OF RHIZOMA DRYNARIAE IN PREPARATION OF MEDICINE FOR TREATING ORTHOPEDIC DISEASES | The Third Affiliated Hospital of Guangzhou University of Chinese Medicine (CN) | 2025-01-02 | — | — | US | claimed |
| WO-2023219526-A1 | MULTITARGET ANTIVIRAL DIETARY SUPPLEMENT | PROKIN MILAN (RS) | 2023-11-16 | — | — | WO | claimed |
| US-20230293416-A1 | A stabilizer for an emulsion composition | Hayashibara Co., Ltd. (JP) | 2023-09-21 | — | — | US | claimed |
| WO-2023155398-A1 | USE OF EXTRACELLULAR VESICLES OF RHIZOMA DRYNARIAE IN PREPARATION OF MEDICINE FOR TREATING ORTHOPEDIC DISEASES | 广州中医药大学第三附属医院 | 2023-08-24 | — | — | WO | claimed |
| CN-116555379-A | Use of alpha-L-rhamnosidase St-rRNA with high temperature resistance and methanol resistance and application thereof | 集美大学 | 2023-08-08 | — | — | CN | claimed |
| CN-115851856-A | Preparation process of pulutinine | 成都欧康医药股份有限公司 | 2023-03-28 | — | — | CN | claimed |
| EP-4108323-A1 | STABILIZER FOR EMULSION COMPOSITION | Hayashibara Co., Ltd. (JP) | 2022-12-28 | — | — | EP | claimed |
| CN-115135299-A | Stabilizer for emulsified composition | 株式会社林原 | 2022-09-30 | — | — | CN | claimed |
| US-7887868-B2 | low-salt soy sauce having an antihypertensive effect; contains 3.55% or less by weight of sodium, 0.5% to 3.6% by weight of potassium, 0.05 to 20% by weight of at least one polyphenol | KAO CORPORATION (JP) | 2011-02-15 | — | — | US | claimed |
| US-20100316743-A1 | INHIBITION OF THE FORMATION OF AGEs | BASF BEAUTY CARE SOLUTIONS FRANCE S.A.S. (FR) | 2010-12-16 | — | — | US | claimed |
| US-7727524-B2 | Low sodium liquid seasoning with anti-hypertensive activity | KAO CORPORATION (JP) | 2010-06-01 | — | — | US | claimed |
| CN-101686954-A | The inhibition that AGE forms | BASF BEAUTY CARE SOLUTIONS F | 2010-03-31 | — | — | CN | claimed |
| US-20090170928-A1 | Synthesis of oligo/poly(catechins) and methods of use | GOVERNMENT OF THE UNITED STATES | 2009-07-02 | — | — | US | claimed |
| WO-2006116532-A2 | SYNTHESIS OF OLIGO/POLY(CATECHINS) AND METHODS OF USE | UNIVERSITY OF MASSACHUSETTS LOWELL (US) | 2006-11-02 | — | — | WO | claimed |
| US-6583118-B1 | Administering glycosides or flavonoids such as apigenin as antiarthritic agents and to prevent glycoprotein exhaustion from chondrocytes | KUREHA CHEMICAL INDUSTRY CO., LTD. (JP) | 2003-06-24 | — | — | US | claimed |
| EP-0719554-A1 | Chondroprotective flavonoids | Kureha Chemical Industry Co., Ltd. (JP) | 1996-07-03 | — | — | EP | claimed |
| EP-0633022-A2 | Chondroprotective flavones | KUREHA CHEMICAL INDUSTRY CO., LTD. (JP) | 1995-01-11 | — | — | EP | claimed |
| US-4617293-A | Flavonoid phosphate salts of aminoglycoside antibiotics | MERCK PATENT GESELLSCHAFT MIT BESCHRAENKTER HAFTUNG (DE) | 1986-10-14 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100316743-A1 | INHIBITION OF THE FORMATION OF AGEs | AGER, GLA, S100A6 | SLCO2B1 4631/4885PTPN1 2842/4885SYNJ2 3632/4885 |
| US-20090170928-A1 | Synthesis of oligo/poly(catechins) and methods of use | POLI, PUF60, FABP3 | SLCO2B1 596/4885PTPN1 3445/4885SYNJ2 2312/4885 |
| US-20230293416-A1 | A stabilizer for an emulsion composition | PIGS, UGCG, GBA2 | SLCO2B1 1209/4885PTPN1 1131/4885SYNJ2 68/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.